Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

Search research articles

Home
Research Domains
Biomedical And Clinical Sciences
Oncology And Carcinogenesis
Predictive And Prognostic Markers
Hypoxia In Uterine Fibroids: Role In Pathobiology And Therapeutic Opportunities.

Home
Research Domains
Biomedical And Clinical Sciences
Oncology And Carcinogenesis
Predictive And Prognostic Markers
Hypoxia In Uterine Fibroids: Role In Pathobiology And Therapeutic Opportunities.

Related Experiment Video

Induction and Testing of Hypoxia in Cell Culture

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Hypoxia in uterine fibroids: role in pathobiology and therapeutic opportunities.

Sydney L Olson¹, Razeen J Akbar², Adrianna Gorniak¹

¹Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.

Oxygen (Basel, Switzerland)

|July 3, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Hypoxia drives uterine fibroid growth by promoting cell proliferation, DNA damage, and excess extracellular matrix. Targeting hypoxia pathways offers new therapeutic strategies for these common tumors.

Keywords:

HIF fibroids hypoxia leiomyoma

More Related Videos

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Related Experiment Videos

Induction and Testing of Hypoxia in Cell Culture

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Area of Science:

Gynecology
Oncology
Cell Biology

Background:

Uterine fibroids are common tumors in women, with limited targeted therapies.
Oxidative stress and hypoxia are increasingly recognized as key drivers of fibroid pathogenesis.
Hypoxia influences cell transformation, extracellular matrix, and signaling pathways in uterine biology.

Purpose of the Study:

To elucidate the role of hypoxia in uterine fibroid development and growth.
To explore the interplay between hypoxia signaling and common fibroid-associated mutations.
To identify potential hypoxia-targeting therapeutic strategies for uterine fibroids.

Main Methods:

Review of pre-clinical and clinical studies on fibroid pathogenesis and hypoxia.
Analysis of molecular pathways involved in hypoxia-induced fibroid growth, including HIF-1, TGFβ, and Wnt/β-catenin.

reactive oxygen species

uterine fibroids

Investigation of common fibroid-associated mutations (MED12, HMGA2, Fumarate hydratase) in relation to hypoxia signaling.

Main Results:

Hypoxia promotes fibroid tumorigenesis by enhancing myometrial stem cell proliferation, causing DNA damage, and increasing extracellular matrix (ECM) production.
Hypoxia signaling interacts with common fibroid mutations like MED12, HMGA2, and Fumarate hydratase loss.
Persistent fibroid hypoxia is linked to antioxidant imbalance, ECM accumulation, and inadequate vascular supply.

Conclusions:

Hypoxia is a critical factor in uterine fibroid development and progression.
Targeting hypoxia-mediated pathways, including HIF-1, TGFβ, and Wnt/β-catenin, holds promise for novel uterine fibroid therapies.
Current treatments do not leverage hypoxia-targeting strategies, highlighting a gap in clinical management.